July 6, 2018

Please reload

Recent Posts

FDA Comments on Recently Released Rare Disease Guidance for Industry

September 16, 2015

Jonathan Goldsmith, M.D., F.A.C.P., FDA’s Associate Director, Rare Diseases Program, Center for Drug Evaluation and Research, comments on the recently...

1/2
Please reload

Featured Posts

The Rise in Orphan Drug Designations: Meeting the Growing Demand

July 18, 2016

The official blog of the FDA recently published an article on their efforts to maintain efficiency despite a record number of Orphan Drug requests. Read through the article below for further details: http://blogs.fda.gov/fdavoice/index.php/2016/07/the-rise-in-orphan-drug-designations-meeting-the-growing-demand/

Please reload

Patagonia Pharmaceuticals, LLC

50 Tice Blvd, Suite A26

Woodcliff Lake, NJ 07677

For more info: info@patagoniarx.com

© 2019 by Patagonia Pharmaceuticals, LLC